Beyond Acute EGFR Blockade: Biological Basis and Clinical Evidence for Long-Term Nimotuzumab Therapy.

Crombet Ramos T, Díaz Miqueli A, Pérez Rodríguez R

Open source

DOI
10.3390/biomedicines14071570
Published
2026 Jul 14
Container
Biomedicines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines14071570,
  title = {Beyond Acute EGFR Blockade: Biological Basis and Clinical Evidence for Long-Term Nimotuzumab Therapy.},
  author = {Crombet Ramos T and Díaz Miqueli A and Pérez Rodríguez R},
  year = {2026},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines14071570},
  url = {https://doi.org/10.3390/biomedicines14071570}
}

RIS

TY  - JOUR
TI  - Beyond Acute EGFR Blockade: Biological Basis and Clinical Evidence for Long-Term Nimotuzumab Therapy.
AU  - Crombet Ramos T
AU  - Díaz Miqueli A
AU  - Pérez Rodríguez R
PY  - 2026
JO  - Biomedicines
DO  - 10.3390/biomedicines14071570
UR  - https://doi.org/10.3390/biomedicines14071570
ER  - 

APA

T, C. R., A, D. M., & R, P. R. (2026). Beyond Acute EGFR Blockade: Biological Basis and Clinical Evidence for Long-Term Nimotuzumab Therapy.. Biomedicines. https://doi.org/10.3390/biomedicines14071570

Source records